Gelonghui, March 3rd: Hengrui Pharma (01276.HK) announced that on March 3, 2026, it repurchased 630,000 A-shares for RMB 33.9821 million at a price of RMB 53.52 to 54.27 per share.
Hengrui Pharma (01276.HK) repurchased 630,000 A-shares at a cost of 33.9821 million yuan on March 3.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Market Insights
Hot Stock Hot Stock
Top HK stocks viewed in the last 24 hours, capturing market sentiment and key capital flow insights. Top HK stocks viewed in the last 24 hours, capturing market sentiment and key capital flow insights.
View More
Hot Topics Hot Topics
[2026 Outlook] Plan Ahead! Share the Investment Opportunities You Are Optimistic About
係時候要部署！2026年，「股債金匯幣」等各大類資產將如何風雲變色？下一個投資方向會喺邊？AI狂潮之後，仲有邊啲機會、產業值得發掘？面對市場波動，如何穩捉機遇避開陷阱？歡迎分享你嘅2026年投資藍圖！一起集思廣益，為新年投資鋪好盈利之路～👉查看詳細規則>>
牛牛課堂
Jan 15 17:36
2026 Outlook | Recommended to bookmark! Where are the investment opportunities in 2026? This article identifies four core sectors and 13 golden industries.
今日熱門
Jan 12 09:52
Win Prizes! [Niuniu Special Issue #11] 2025 Edition: Fellow Investors’ Winning Guide to Navigating Market Volatility